Prostate cancer is the most common solid organ cancer in American men and the second leading cause of cancer-related death ...

MRI around the time of diagnostic biopsy may identify patients at increased risk for early reclassification during prostate cancer active surveillance.

While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi ...

Prostate cancer screening can help detect signs of cancer before symptoms start. It’s essential for men to talk with their ...

Adding external beam radiotherapy did not improve biochemical failure outcomes or prostate cancer specific mortality in ...

Cancer doctors, scientists, and patient advocates said the “cancer” label can do more harm than good, given this form of the ...

Receiving a prostate cancer diagnosis can be life-altering, both mentally and physically. It's a moment filled with ...

For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who ...

Prostate cancer is the most commonly diagnosed cancer in males in 118 of 185 countries, but it's the leading cause of death ...

Follow-up tests included a prostate MRI, which showed a suspicious spot for cancer on one side of the prostate. An ...

HOUSTON — September is Prostate Cancer Awareness Month. One in eight men will be diagnosed during their lifetime, and it's ...

A broad coalition of health experts, policymakers, development partners, and civil society organizations convened at the ...